Oncology PracticeImmunotherapy’s cardiac effects require early monitoring, managementFebruary 5, 2019Immuno-oncologyImmunotherapyThrombosisPatient & Survivor CareMelanomaLeukemia, Myelodysplasia, TransplantationALL
Oncology PracticeThe personal cancer vaccine NEO-PV-01 shows promise in metastatic cancersFebruary 1, 2019Immuno-oncologyMelanomaLung CancerGenitourinary Cancer
Oncology PracticePoor-prognosis cancers linked to highest suicide risk in first yearJanuary 7, 2019Patient & Survivor CareBreast CancerGenitourinary CancerLung CancerGastroenterologyMelanomaGastrointestinal Cancer
Oncology PracticeRCC strongly linked to melanoma, and vice versaDecember 10, 2018Renal Cell CarcinomaGenitourinary CancerMelanoma
The Journal of Community and Supportive OncologyBRAF-MEK inhibitor combo approved for adjuvant melanoma therapyDecember 6, 2018Melanoma
Oncology PracticeA novel tracer shows promise for detecting CD8 T-cells in advanced solid tumorsNovember 30, 2018Immuno-oncologyMelanomaLung CancerGastroenterologyGastrointestinal Cancer
Oncology PracticeSRS beats surgery in early control of brain mets, advantage fades with timeNovember 9, 2018CNS/Brain CancerBreast CancerMelanomaGastroenterologyGenitourinary CancerRenal Cell CarcinomaGastrointestinal Cancer
Oncology PracticeCirculating tumor DNA identified by fragment sizeNovember 7, 2018Gynecologic CancerGenitourinary CancerBreast CancerRenal Cell CarcinomaCNS/Brain CancerMelanoma
Oncology PracticeNivo + ipi shows durable activity against metastatic melanomaOctober 31, 2018Immuno-oncologyMelanoma
Oncology PracticeCheckpoint inhibitor doubles 3-year survival rate of BRAF wild-type advanced melanomaOctober 25, 2018Immuno-oncologyMelanoma
Oncology PracticeCheckpoint inhibitor seems safe and effective for patients with HIVOctober 23, 2018Immuno-oncologyMelanomaLung Cancer
Oncology PracticeEpacadostat plus pembrolizumab shows promise in advanced solid tumorsOctober 5, 2018Immuno-oncologyMelanomaRenal Cell CarcinomaLung CancerHead & Neck/Thyroid CancersGynecologic Cancer
